Calidi Biotherapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $14.5M | $231.2M | $597.5K |
| Jun 2022 | $10.1M | $231.0M | $328.8K |
| Sep 2022 | $10.4M | $42.2M | $300.0K |
| Dec 2022 | $43.4M | $2.6M | $590.0K |
| Mar 2023 | $8.2M | $43.2M | $1.1M |
| Jun 2023 | $12.8M | $44.0M | $2.3M |
| Sep 2023 | $19.7M | $18.6M | $10.4M |
| Dec 2023 | $18.3M | $10.0M | $2.2M |
| Mar 2024 | $22.0M | $7.4M | $1.2M |
| Jun 2024 | $18.2M | $6.4M | $800.0K |
| Sep 2024 | $16.5M | $6.7M | $1.9M |
| Dec 2024 | $12.2M | $14.2M | $9.6M |
| Mar 2025 | $7.8M | $15.1M | $10.8M |
| Jun 2025 | $7.3M | $9.4M | $5.4M |
| Sep 2025 | $6.8M | $14.0M | $10.6M |
| Dec 2025 | $5.1M | $8.9M | $5.8M |
| Mar 2026 | $4.7M | $9.6M | $6.9M |
| Jun 2026 | $4.1M | $7.2M | $4.3M |